Recent Publications

Cryopreserved Amniotic Membrane Using the TissueTuck Technique: A Sutureless Approach for Pterygium Surgery

This groundbreaking study led by Neel Desai, MD, was published last week that uncovers how the use of AmnioGraft®, our cryopreserved amniotic membrane graft, can be performed in minimal time (less than 15 mins) and result in a low recurrence (less than 1%) after pterygium surgery. Pterygium, also known as surfer’s eye, is a raised, […]

Redefining the Standard of Care: A Consensus Guideline

5 renowned experts (Marguerite McDonald, MD; Neel Desai, MD; Clifford Salinger, MD; Mark Milner, MD; John Sheppard, MD) in anterior segment eye disease and surgery will highlight their recommendations for the use of CAM in the following indications: persistent epithelial defect (PED), corneal ulcer/infectious keratitis, recurrent corneal erosion (RCE), severe dry eye disease (DED), epithelial […]

Injectable Amniotic Membrane/Umbilical Cord Particulate for Knee Osteoarthritis

This is a prospective, single-center pilot study, designed to evaluate the short-term safety and effectiveness of amniotic membrane/umbilical cord particulate (AMUC) in managing pain in patients with various severities of knee osteoarthritis (OA). Read more

An Open Label Trial of Cryopreserved Human Umbilical Cord in the Treatment of Complex Diabetic Foot Ulcers Complicated by Osteomyelitis

The results of this multicenter, open-label, Phase 2 study suggest that cryopreserved umbilical cord allograft (TTAX01) is a promising therapy for the management of complex, non-healing diabetic foot ulcers complicated by osteomyelitis… read more.

Effects of Cryopreserved Amniotic Membrane-Umbilical Cord Allograft on Total Ankle Arthroplasty Wound Healing

The results from this prospective, controlled, randomized trial show adjunctive treatment with umbilical cord allograft (CLARIX® CORD) significantly decreased the overall time to skin healing (28.5 days vs 40 days; p = .03) after total ankle arthroplasty… read more.